scholarly journals Antibody responses in buffalos immunized with Clostridium perfringens beta and epsilon toxoids

2001 ◽  
Vol 46 (No. 9–10) ◽  
pp. 241-243 ◽  
Author(s):  
S. Rahman M ◽  
K. Baek B ◽  
T. Hong S ◽  
H. Lee J
Keyword(s):  
Antibody Titre ◽  
Clostridium Perfringens ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Control Group ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Antibody Titres ◽  
Group A ◽  
And Control

The antibody responses to toxoids were measured to investigate whether Clostridium perfringens beta and epsilon toxoids induced protective humoral immune responses in buffalos. Total of 24 buffalos were divided into 4 groups (n = 6), beta toxoid, epsilon toxoid, combination and control groups. These buffalo groups were administered each of the designated toxoids. Immunizations in the beta and epsilon toxoid groups induced strong antibody responses. The neutralizing antibody titres from the beta and epsilon toxoid groups were equally log101.2 on day 21 after inoculation whereas there was no antibody titre detected from the control group. A statistically significant (P < 0.01) increase in antibody titre was observed from day 0 to day 14 and 21 after inoculation. The antibody production did not vary significantly due to day of inoculation and toxoid interactions.

scholarly journals Development of BHK-21 Cell line Adapted Inactivated Newcastle Disease Vaccine

2014 ◽  
Vol 3 (1) ◽  
pp. 1-4
Author(s):  
Md Enamul Haque ◽  
Mohammed Ferdousur Rahman Khan ◽  
Marzia Rahman ◽  
Md Tanvir Rahman ◽  
Sukumar Saha ◽  
...  
Keyword(s):  
Cell Line ◽  
Antibody Titre ◽  
Newcastle Disease ◽  
Fusion Gene ◽  
Vaccination Schedule ◽  
Control Group ◽  
Inactivated Vaccine ◽  
Outbreak Area ◽  
Antibody Titres ◽  
And Control

The present study was undertaken to isolate and characterize Newcastle disease virus (NDV) from the outbreak of layer farms for the development of BHK-21 cell adapted inactivated vaccine. A total of 6 dead birds were brought to the laboratory from the outbreak area from which 18 samples (trachea, liver and brain from each) were collected. Among them 3 samples were found positive for NDV through chicken embryo inoculation followed by HA test. The MDT, ICPI, IVPI of all isolates was 54.4, 1.56, and 2.20 respectively which revealed that the field isolates were velogenic. The isolated viruses were confirmed as NDV by reverse transcription-polymerase chain reaction (RT-PCR) using fusion gene-specific primers. The isolated virus was used to infect the BHK-21 cell line. Later the BHK-21 cell adapted viruses were used to develop oil adjuvanted inactivated vaccine and were inoculated into chickens according to vaccination schedule. The MDA was very high (112±29.62) during BCRDV vaccination, which declined quickly (88±33.12). Before vaccination with experimental vaccine, the level of antibody titre (HI) was very low (9±4.65). After vaccination at 65th day through IM, ELD50=109.7/ml with experimental vaccine, the highest HI titre in RDV vaccinated group was 160±59.25 whereas, experimental vaccinated group was 128±59.25, and control group was 7±4.65. ELISA antibody titres of all the groups were 2549.71 (RDV, [email protected] ml/bird), 2450.37 (experimental@ 0.25ml/ bird), 2218.579 (experimental@ 0.50ml/bird), 2152.352 (experimental@1ml/bird) 1125.846 (control) respectively. The present study indicated that, BHK-21 cell adapted ND inactivated vaccine produced a satisfactory antibody titre along with conventional live RDV vaccine.DOI: http://dx.doi.org/10.3329/mh.v3i1.19729 Microbes and Health, June 2014. 3(1): 1-4

scholarly journals Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients

2021 ◽  
Author(s):  
Jennifer M. Sasson ◽  
Joseph J. Campo ◽  
Rebecca M. Carpenter ◽  
Mary K. Young ◽  
Arlo Z. Randall ◽  
...  
Keyword(s):  
Older Adult ◽  
Protein Microarray ◽  
Antibody Responses ◽  
Clinical Severity ◽  
Protein Fragments ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Cytokine Analysis ◽  
Group A ◽  
Varying Length

AbstractWe sought to discover links between antibody responses to SARS-CoV-2 and patient clinical variables, cytokine profiles and antibodies to endemic coronaviruses. Serum from patients of varying ages and clinical severity were collected and used to probe a novel multi-coronavirus protein microarray containing SARS-CoV-2 proteins and overlapping protein fragments of varying length as well as SARS-CoV, MERS-CoV, HCoV-OC43 and HCoV-NL63 proteins. IgG, IgA and IgM antibody responses to specific epitopes within the spike (S), nucleocapsid (N) and membrane proteins (M) were higher in older adult patients. Moreover, the older age group displayed more consistent correlations of antibody reactivity with systemic cytokine and chemokine responses when compared to the younger adult group. A subset of patients, however, had little or no response to SARS-CoV-2 antigens and disproportionately severe clinical outcomes. Further characterization of these serosilent individuals with cytokine analysis revealed significant differences in IL-10, IL-15, IP-10, EGF and sCD40L levels when compared to seroreactive patients in the cohort.

scholarly journals Effect of vitamins, minerals and probiotics on production of antibody and live weight gain following vaccination with BCRDV in broiler birds

1970 ◽  
Vol 6 (1) ◽  
pp. 31-36 ◽  
Author(s):  
P Monoura ◽  
M Rahman ◽  
MFR Khan ◽  
MB Rahman ◽  
MM Rahman
Keyword(s):  
Antibody Titre ◽  
Serum Antibody ◽  
Live Weight ◽  
Poultry Feed ◽  
Control Group ◽  
Broiler Chicks ◽  
Antibody Titres ◽  
Group A ◽  
Group B ◽  
Group D

The effect of vitamins, minerals and probiotics supplementation to the balanced ration of the broiler chicks on the immune response and growth performance after vaccination with BCRDV was evaluated. For this 50 broiler birds were divided into five equal groups such as A, B, C, D and E, and five types of separate treatments with normal poultry feed were provided to the indivisual experimental groups. All the birds were vaccinated with BCRDV primarily at 3 days of age and boostered at 17 days of age. The birds of group A, B, C and D were supplemented with only probiotics, mixture of probiotics and minerals, mixture of probiotics, minerals and vitamins, respectively. The birds of group E were kept as vaccinated control. Blood samples were collected at the age of 9, 12, 16, 23, 26 and 30 days sequencially. The serum antibody titres were measured by HI test and ELISA. The highest value of HI antibody titre was 384±242.65 (Mean ±SD) in group B at 23 days of age. The lowest value of HI at 23 days was 56±32.86 (Mean ±SD) obtained in group C. The ELISA antibody titre was also highest (4675.12±485.72) at 23 days in group B and obviously the lowest (2169.38±724.45) in control group E. In case of group C, the ELISA antibody titre was 3105.73±877.57 at 23 days but then the titre decreased gradually compared to control group. The highest body weight (1420±90.82) was recorded at 30 days of age in group D and the lowest value (1188±44.38) was in group B. Key words: Probiotics, BCRDV, broiler birds DOI = 10.3329/bjvm.v6i1.1336 Bangl. J. Vet. Med. (2008). 6 (1): 31-36

scholarly journals Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain

Blood ◽  
2009 ◽  
Vol 113 (18) ◽  
pp. 4250-4261 ◽  
Author(s):  
Thaidra Gaufin ◽  
Rajeev Gautam ◽  
Melissa Kasheta ◽  
Ruy Ribeiro ◽  
Erin Ribka ◽  
...  
Keyword(s):  
Immune Responses ◽  
Antibody Production ◽  
Neutralizing Antibody ◽  
Viral Loads ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Significant Difference ◽  
Anti Cd20 ◽  
And Control ◽  
The Impact

AbstractWe investigated the impact of rhesus macaque (RM) B-cell depletion before inoculation with the isolate SIVsmmD215. Seven RMs were treated every 3 weeks with 50 mg/kg of an anti-CD20 antibody (rituximab) starting 7 days before inoculation for 2 (n = 4) and 5 (n = 3) months. Four control animals received no antibody. Three animals were completely depleted of CD20+ B cells, but 4 were only partially depleted of CD20 cells in the LNs and intestine. The decrease in antibody production was consistent with the efficacy of tissue CD20 depletion. Seroconversion and neutralizing antibody production was significantly delayed in animals showing complete tissue CD20 depletion and remained at low titers in all CD20-depleted RMs. Surprisingly, there was no significant difference in acute or chronic viral loads between CD20-depleted and control animal groups. There was a tendency for lower viral set points in CD20-depleted animals. At 6 weeks after inoculation, cellular immune responses were significantly stronger in CD20-depleted animals than in controls. There was no significant difference in survival between CD20-depleted and control animals. Our data suggest that a deficiency of Ab responses did not markedly affect viral replication or disease progression and that they may be compensated by more robust cellular responses.

scholarly journals Efficacy study of bio-typhoid® vaccine against fowl typhoid in backyard layer chicken

1970 ◽  
Vol 7 (2) ◽  
pp. 295-299
Author(s):  
MZ Uddin ◽  
MSR Khan ◽  
F Begum ◽  
MA Mannan
Keyword(s):  
Antibody Titre ◽  
Virulent Strain ◽  
Primary Vaccination ◽  
Control Group ◽  
Fowl Typhoid ◽  
Layer Chicken ◽  
Unvaccinated Control ◽  
Antibody Titres ◽  
Group A ◽  
Group B

The study was performed with a view to isolate and identify a virulent strain of S. gallinarum and determine the purity, safety and efficacy of BIO-TYPHOID® vaccine. A total of 40 backyard layer chicken were used for this study where Group A was used for experimental vaccination, Group B kept as control and Group C was used for calculating virulent S. gallinarum challenge dose. Primary and secondary vaccination was carried out at 40 days and 110 days of age, respectively. Blood samples were collected to obtain the sera after vaccination from both vaccinated and unvaccinated control group and antibody titres were determined by Microplate agglutination test. The antibody titre increased in primary vaccination up to days 56 days post vaccination (DPV) and then decreased gradually. The highest antibody titre (Mean ± SE) 384.00 ± 42.67 was obtained at 91 DPV (21 days later of secondary vaccination) and maintained up to 98 DPV. Safety test was done by inoculating mice and purity test of the vaccine was done by inoculating on to Blood Agar media. The efficacy of BIO-TYPHOID® vaccine was recorded as 90% which was determined by challenge infection with 0.1 ml of 5x105 CFU virulent S. gallinarum. Results of this study revealed successful protections by BIO-TYPHOID® vaccine. Keywords: BIO-TYPHOID® vaccine; Chicken; Efficacy; Fowl Typhoid DOI: 10.3329/jbau.v7i2.4737 J. Bangladesh Agril. Univ. 7(2): 295-299, 2009

scholarly journals Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents

2021 ◽  
Author(s):  
Carolina Garrido ◽  
Jillian H Hurst ◽  
Cynthia G. Lorang ◽  
Jhoanna N. Aquino ◽  
Javier Rodriguez ◽  
...  
Keyword(s):  
Immune Responses ◽  
Children And Adolescents ◽  
Acute Infection ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Symptomatic Infection ◽  
Neutralizing Activity ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Broad Array

As SARS-CoV-2 continues to spread globally, questions have emerged regarding the strength and durability of immune responses in specific populations. In this study, we evaluated humoral immune responses in 69 children and adolescents with asymptomatic or mild symptomatic SARS-CoV-2 infection. We detected robust IgM, IgG, and IgA antibody responses to a broad array of SARS-CoV-2 antigens at the time of acute infection and 2 and 4 months after acute infection in all participants. Notably, these antibody responses were associated with virus neutralizing activity that was still detectable 4 months after acute infection in 94% of children. Moreover, antibody responses and neutralizing activity in sera from children and adolescents were comparable or superior to those observed in sera from 24 adults with mild symptomatic infection. Taken together, these findings indicate children and adolescents with mild or asymptomatic SARS-CoV-2 infection generate robust and durable humoral immune responses that are likely to protect from reinfection.

scholarly journals Studies onEmblica officinalisDerived Tannins for Their Immunostimulatory and Protective Activities against Coccidiosis in Industrial Broiler Chickens

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Qari Muhammad Kaleem ◽  
Masood Akhtar ◽  
Mian Muhammad Awais ◽  
Muhammad Saleem ◽  
Muddassar Zafar ◽  
...  
Keyword(s):  
Broiler Chickens ◽  
Protective Efficacy ◽  
Moderate Intensity ◽  
Control Group ◽  
Broiler Chicks ◽  
Intestinal Lesion ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Daily Body Weight ◽  
And Control

The present study reports the effect ofEmblica officinalis(EO) derived tannins on humoral immune responses and their protective efficacy againstEimeriainfection in chickens. Tannins were extracted from EO and characterized by HPLC. EO derived tannins (EOT) and commercial tannins (CT) were orally administered in broiler chicks in graded doses for three consecutive days, that is, 5th-7th days of age. On day 14 after administration of tannins, humoral immune response was detected against sheep red blood cells (SRBCs) by haemagglutination assay. Protective efficacy of tannins was measured against coccidial infection, induced byEimeriaspecies. Results revealed higher geomean titers against SRBCs in chickens administered with EOT as compared to those administered with CT and control group. Mean oocysts per gram of droppings were significantly lower (P<0.05) in EOT administered chickens as compared to control group. Lesion scoring also showed the lowest caecal and intestinal lesion score of mild to moderate intensity in chickens administered with EOT. Further, significantly higher (P<0.05) daily body weight gains and antibody titers were detected in EOT administered chickens as compared to those of CT administered and control groups. EOT showed the immunostimulatory properties in broilers and their administration in chickens boost the protective immunity against coccidiosis.

scholarly journals IgA dominates the early neutralizing antibody response to SARS-CoV-2

2020 ◽  
pp. eabd2223 ◽  
Author(s):  
Delphine Sterlin ◽  
Alexis Mathian ◽  
Makoto Miyara ◽  
Audrey Mohr ◽  
François Anna ◽  
...  
Keyword(s):  
Neutralizing Antibodies ◽  
Neutralizing Antibody ◽  
Antibody Responses ◽  
Immune Memory ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Virus Specific Antibody ◽  
Iga Response ◽  
Humoral Responses ◽  
Antibody Secreting Cells

Humoral immune responses are typically characterized by primary IgM antibody responses followed by secondary antibody responses associated with immune memory and comprised of of IgG, IgA and IgE. Here we measured acute humoral responses to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of SARS-CoV-2-specific neutralizing antibodies in the serum, saliva and broncho-alveolar fluid of 159 patients with COVID-19. Early SARS-CoV-2-specific humoral responses were dominated by IgA antibodies. Peripheral expansion of IgA plasmablasts with mucosal-homing potential was detected shortly after the onset of symptoms and peaked during the third week of the disease. The virus-specific antibody responses included IgG, IgM and IgA, but IgA contributed to virus neutralization to a greater extent compared with IgG. Specific IgA serum concentrations decreased notably one month after the onset of symptoms, but neutralizing IgA remained detectable in saliva for a longer time (days 49 to 73 post symptoms). These results represent a critical observation given the emerging information as to the types of antibodies associated with optimal protection against re-infection, and whether vaccine regimens should consider targeting a potent but potentially short-lived IgA response.

scholarly journals Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

Vaccines ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 360
Author(s):  
Michael Jahn ◽  
Johannes Korth ◽  
Oliver Dorsch ◽  
Olympia Evdoxia Anastasiou ◽  
Burkhard Sorge-Hädicke ◽  
...  
Keyword(s):  
Humoral Response ◽  
Antibody Responses ◽  
Control Group ◽  
Immune Reactivity ◽  
Preventive Strategy ◽  
Protective Effects ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Vulnerable Patients ◽  
Antibody Titers

mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of patients on hemodialysis (HDP). We measured humoral immune responses in 72 HDP after standard vaccination with two doses of the mRNA-based SARS-CoV-2 vaccine BNT162b2 (Pfizer-BioNTech). Antibody responses were evaluated with an anti-SARS-CoV-2 IgG ChemiLuminescent ImmunoAssay (CLIA) two weeks after the second dose. In addition, SARS-CoV-2 IgG was determined in a control of 16 healthy healthcare workers (HCW). The control group of HCW has shown a strong antibody response with a median (MD (Q1; Q3)) antibody titer of 800.0 AU/mL (520.5; 800.0). In comparison to HCW, HDP under 60 years of age responded equally (597.0 AU/mL (410.5; 800.0), p = 0.051). However, the antibody responses of the HDP negatively correlated with age (r2 = 0.2954 p < 0.0001), leading to significantly lower antibody titers in HDP over 60 years (280.0 AU/mL (45.7; 477.0), p < 0.0001). To thoroughly understand the immunogenicity of the new mRNA-based vaccines in HDP, longitudinal data on the effectiveness and durability of antibody responses are needed. Modifications of immunization schedules should be considered in HDP with low or without antibody responsiveness after standard vaccination to boost immune reactivity and prolong protective effects in these vulnerable patients.

scholarly journals Different formulations of inactivated SARS-CoV-2 vaccine candidates in human compatible adjuvants: Potency studies in mice showed different platforms of immune responses

2021 ◽  
Author(s):  
Melika Haghighi ◽  
Akbar khorasani ◽  
Pegah Karimi ◽  
Rouhollah Keshavarz ◽  
Mehdi Mahdavi
Keyword(s):  
Immune Responses ◽  
Control Group ◽  
Control Groups ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Igg2a Level ◽  
Specific Igg ◽  
Ifn Γ ◽  
And Control ◽  
Ctl Activity

Abstract Several inactivated SARS-CoV-2 vaccines were approved for human use but are not highly potent. Here, different formulations of inactivated SARS-CoV-2 virus in Alum, Montanide 51VG and Montanide ISA720VG adjuvants were developed and then immune responses were assessed. SARS-CoV-2 virus was inactivated with formalin and formulated in the adjuvants. BALB/c mice were immunized subcutaneously with 4µg of experimental vaccines on days 0 and 14 and two weeks after the final immunization, IL-4 and IFN-γ cytokines, CTL activity and specific IgG titer and IgG1, IgG2a, IgG2a/IgG1 ratio and also anti-RBD IgG response were assessed. Immunization with SARS-CoV-2-Montanide ISA51VG showed a significant increase in IFN-γ cytokine versus SARS-CoV-2-Alum, SARS-CoV-2-Montanide ISA720VG and control groups (P<0.0033). Cytokine IL-4 response in SARS-CoV-2-Alum group showed a significant increase versus SARS-CoV-2-Montanide ISA51VG, SARS-CoV-2-Montanide ISA720VG and control groups (P<0.0206). In addition, SARS-CoV-2-Montanide ISA51VG vaccine induced the highest IFN-γ/IL-4 cytokine ratio versus other groups (P<0.0004). CTL activity in SARS-CoV-2- Montanide ISA51 VG and SARS-CoV-2-Montanide ISA720 VG groups showed a significant increase versus SARS-CoV-2-Alum and control groups (P<0.0075). Specific IgG titer in SARS-CoV-2- Montanide ISA51 VG and SARS-CoV-2-Montanide ISA720VG showed significant increase versus SARS-CoV-2-Alum and control groups (P<0.0143). Results of specific IgG1and IgG2a level in SARS-COV-2-Alum, SARS-COV-2-Montanide ISA51VG and SARS-COV-2-Montanide ISA720VG vaccine showed a significant increase versus the control group (P<0.0001) but SARS-COV-2-Montanide ISA51VG and SARS-COV-2-Montanide ISA 720VG groups showed highest IgG2a/IgG1 ratio and a significant increase versus SARS-COV-2-Alum group (P<0.0379). Results of anti-RBD IgG response showed that inactivated SARS-COV-2+Alum and SARS-COV-2-Montanide ISA 720VG vaccine groups demonstrated a significant increase versus SARS-COV-2-Montanide ISA51VG group. It seems that the type of vaccine formulation is a critical parameter that effect on immunologic patterns and vaccine potency. Here, results showed that human compatible oil-based adjuvants were more potent than Alum adjuvant in the induction of cellular and humoral immune responses versus SARS-CoV-2 virus.

Sign in / Sign up

Export Citation Format

Share Document